logo
NC Congressman seeks to expand veteran services, data about suicides

NC Congressman seeks to expand veteran services, data about suicides

Yahoo27-05-2025

RALEIGH, N.C. (WNCN) — On this Memorial Day, North Carolina Congressman Chuck Edwards says the Department of Veterans Affairs needs to do more to protect veterans, and he's introducing legislation to help.
'These are folks that have served our country, that deserve the very best that we can give them,' said Edwards (R-11).
The Justice for America's Veterans and Survivors Act calls on the Department of Veterans Affairs to properly document causes of death for veterans across the country and note if suicide was a factor in an annual report.
Current VA data shows on average, 22 veterans commit suicide every single day.
Edwards says better reporting will help Congress pass legislation to improve mental health treatment for veterans and help surviving family members receive benefits they deserve.
'Given the statistics that we see in America today of so many veterans taking their own lives, it just makes sense to work to get more underneath the data and to fully understand,' Edwards said.
With the legislation, Edwards said he is also planning visits to every military base in North Carolina to hear from servicemembers and their families about what they need.
'After they've taken risks to serve our great nation, we need to do everything we can to make sure that they are healthy once they return into normal society,' Edwards said.
The bill now heads to a committee on Capitol Hill where Edwards says he is expecting wide support for it.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ASCO 2025: Key Updates in Early Breast Cancer Care
ASCO 2025: Key Updates in Early Breast Cancer Care

Medscape

time16 minutes ago

  • Medscape

ASCO 2025: Key Updates in Early Breast Cancer Care

Mariana Chavez MacGregor, MD, MSc, comments on how the ASCO 2025 meeting delivered a wealth of impactful data, particularly in the early-stage breast cancer setting. Trials like neoCARHP and CompassHER2 raised important questions about de-escalating therapy for HER2-positive patients, challenging the role of carboplatin and demonstrating strong pathologic complete response rates with shorter regimens. Long-term data from SOFT and TEXT reinforced the survival benefits of ovarian suppression plus an aromatase inhibitor in high-risk premenopausal patients, and the OASIS 4 study showed promise with elinzanetant in managing vasomotor symptoms. Across subtypes, including triple-negative disease, and with the growing role of AI and circulating tumor DNA, the meeting emphasized more personalized, less toxic approaches to care.

ASCO 2025: Key Highlights in Advanced Lung Cancer
ASCO 2025: Key Highlights in Advanced Lung Cancer

Medscape

time16 minutes ago

  • Medscape

ASCO 2025: Key Highlights in Advanced Lung Cancer

Just returned from ASCO 2025, Isabel Preeshagul, DO, comments on intriguing data that were presented, including results from REZILIENT1, which showed a 35% response rate for zipalertinib in patients with epidermal growth factor receptor exon 20-altered stage IV non-small cell lung cancer (NSCLC), even those previously treated with targeted therapies, with manageable toxicity. An unexpected finding from another study in the advanced NSCLC space suggested that administering immunochemotherapy before 3:00 PM was associated with better outcomes, possibly due to circadian influences on immune response. In extensive-stage small cell lung cancer, tarlatamab demonstrated superiority over chemotherapy in the DeLLphi-304 trial, with favorable patient-reported outcomes including improved cough and exertional shortness of breath. Finally, Dr Preeshagul notes how the IMforte study reported promising results for maintenance atezolizumab plus lurbinectedin, with improved progression-free survival and overall survival, making it a potential option pending further risk-benefit discussion.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store